Clinical Trial Detail

NCT ID NCT01508104
Title Safety Study of BEZ235 With Everolimus in Subjects With Advanced Solid Tumors
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements no
Sponsors University of Cincinnati
Indications

Advanced Solid Tumor

Therapies

BEZ235 + Everolimus

Everolimus

Age Groups: adult senior

No variant requirements are available.